Original Research
Accepted on 27 Jan 2025
Adverse Drug Reactions to Atezolizumab in Combination with Bevacizumab in Hepatocellular Carcinoma Patients: An Analysis of the Food and Drug Administration Adverse Event Reporting System Database
in Pharmacology of Anti-Cancer Drugs